These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 8666505

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pap smear screening in women under 30 in the Norwegian Coordinated Cervical Cancer Screening Program, with a comparison of immediate biopsy vs Pap smear triage of moderate dysplasia.
    Nygård JF, Nygård M, Skare GB, Thoresen SO.
    Acta Cytol; 2006; 50(3):295-302. PubMed ID: 16780024
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer.
    Nygård JF, Skare GB, Thoresen SØ.
    J Med Screen; 2002; 9(2):86-91. PubMed ID: 12133929
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. High-grade cervical abnormalities and cervical cancer in women following a negative Pap smear with and without an endocervical component: a cohort study with 10 years of follow-up.
    Sultana F, English DR, Simpson JA, Canfell K, Gertig DM, Saville M.
    Int J Cancer; 2014 Sep 01; 135(5):1213-9. PubMed ID: 24488882
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Three-year risk of high-grade CIN for women aged 30 years or older who undergo baseline Pap cytology and HPV co-screening.
    Guo M, Khanna A, Wang J, Dawlett MA, Kologinczak TL, Lyons GR, Bassett RL, Sneige N, Gong Y, Bevers TB.
    Cancer Cytopathol; 2017 Aug 01; 125(8):644-651. PubMed ID: 28498639
    [Abstract] [Full Text] [Related]

  • 14. Accuracy of HPV testing of vaginal smear obtained with a novel self-sampling device.
    Stenvall H, Wikström I, Backlund I, Wilander E.
    Acta Obstet Gynecol Scand; 2007 Aug 01; 86(1):16-21. PubMed ID: 17230283
    [Abstract] [Full Text] [Related]

  • 15. Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis.
    Sherman ME, Lorincz AT, Scott DR, Wacholder S, Castle PE, Glass AG, Mielzynska-Lohnas I, Rush BB, Schiffman M.
    J Natl Cancer Inst; 2003 Jan 01; 95(1):46-52. PubMed ID: 12509400
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Are benign cellular changes on a Papanicolaou smear really benign? A prospective cohort study.
    Margolis KL, Carson LF, Setness PA, Stanley MW, Henry-Stanley MJ, Beneke J, Linzie B, McGlennen RC.
    Arch Fam Med; 1999 Jan 01; 8(5):433-9. PubMed ID: 10500518
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Invader human papillomavirus (HPV) type 16 and 18 assays as adjuncts to HPV screening of cervical papanicolaou smears with atypical squamous cells of undetermined significance.
    Wong AK, Chan RC, Nichols WS, Bose S.
    Cancer; 2009 Feb 15; 115(4):823-32. PubMed ID: 19127558
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.